Biotech Growth Trust (The) (LSE:BIOG) GF Value Rank: 2 (As of Aug. 02, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LSE:BIOG Biotech Growth Trust (The) PLC LSE:BIOG
37 GF Score
Price £16.02
! 2 Warning Signs
View Full Analysis

What is Biotech Growth Trust (The) GF Value Rank?

Biotech Growth Trust (The) LSE:BIOG -1.72% 37 GF Value Rank is 2 as of Aug. 02, 2026, which is at its 10-year median of 2.00. GuruFocus rates LSE:BIOG with a GF Score™ of 37/100. The stock has 2 warning signs investors should review.

Biotech Growth Trust (The) has the GF Value Rank of 2.

GF Value Rank evaluates the exclusive GuruFocus valuation and performance of a stock, rated on a scale from 1 to 10. It is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

A higher score indicates a stock with a relatively low valuation and substantial potential for outperformance. Conversely, a lower score often reflects stocks that are either highly overvalued or deeply undervalued, both of which tend to underperform.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.


Biotech Growth Trust (The) GF Value Rank Related Terms


LSE:BIOG vs BLK, BX, KKR: GF Value Rank Comparison

For the Asset Management subindustry, Biotech Growth Trust (The)'s GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotech Growth Trust (The) GF Value Rank vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s GF Value Rank distribution charts can be found below:

* The bar in red indicates where Biotech Growth Trust (The)'s GF Value Rank falls into.


LSE:BIOG
37GF Score
Biotech Growth Trust (The) PLC LSE:BIOG
GF Value Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about GF Value Rank →
What does a GF Value Rank of 2 mean?
Biotech Growth Trust (The) (LSE:BIOG) has a GF Value Rank of 2 as of Aug. 02, 2026. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Biotech Growth Trust (The) and its competitors. This is near median its historical median of 2.00. Over the past decade, Biotech Growth Trust (The)'s GF Value Rank has ranged from 2.00 to 4.00.
Is Biotech Growth Trust (The)'s GF Value Rank too high?
Biotech Growth Trust (The)'s current GF Value Rank of 2 is near median its 10-year median of 2.00. Over the past 10 years, this metric has ranged from a low of 2.00 to a high of 4.00. Overall, Biotech Growth Trust (The) has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s GF Value Rank compare to BLK and BX?
Biotech Growth Trust (The)'s GF Value Rank of 2 can be compared against companies in the Asset Management industry. Historically, Biotech Growth Trust (The)'s own GF Value Rank has ranged from 2.00 to 4.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Value Rank for an Asset Management company?
A good GF Value Rank depends on the Asset Management industry context. However, GF Value Rank should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Value Rank mean?
A high GF Value Rank can signal that a stock is expensive relative to its fundamentals. GF Value Rank is given based on historical multiples along with past returns, growth and future estimates of the business' performance. View historical data on Biotech Growth Trust (The) and its competitors. Biotech Growth Trust (The)'s current GF Value Rank is 2, which is near median its own 10-year median of 2.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current GF Value Rank of 2. The current GF Value Rank is 2, which is near median its 10-year median of 2.00. Biotech Growth Trust (The)'s overall GF Score™ is 37/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Value Rank calculated?
GF Value Rank is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current GF Value Rank is 2 as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Biotech Growth Trust (The) Business Description

Address 25 Southampton Buildings, London, GBR, WC2A 1AL
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
37GF Score

Get the complete analysis for LSE:BIOG

GF Value Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

£16.02
Price